Manamtam, Mizpha Bianca T.
HRN: 26-98-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
CEFUROXIME 1.5GM (VIAL)
05/02/2025
05/03/2025
IV
1.5 GMS
ON CALL TO OR THEN Q 8HRS
NKA
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes